Compounded drugs play a critical role in addressing specific medical needs for patients who may not benefit from commercially available medications. These customized formulations are particularly vital for individuals with unique health conditions, allergies, or those requiring dosage adjustments. However, the practice of drug compounding is not without significant risks, including potential contamination and variability in drug potency, which can lead to adverse patient outcomes.
The increasing reliance on compounded medications has prompted regulatory scrutiny, as agencies like the FDA emphasize the need for stringent oversight to ensure patient safety. This evolving regulatory landscape reflects a broader trend in the pharmaceutical industry, where quality assurance and compliance are paramount. As stakeholders in the pharma B2B sector navigate these complexities, the implications for regulatory, QA/QC, and sourcing professionals are profound, necessitating a proactive approach to risk management and adherence to best practices.
Get started today with Solo access →
